2002
DOI: 10.1111/j.1471-0528.2002.01054.x
|View full text |Cite
|
Sign up to set email alerts
|

A randomised placebo‐controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women

Abstract: Objective To investigate the effectiveness of misoprostol given vaginally for cervical priming before hysteroscopy in postmenopausal women. Design Double-blind randomised controlled study.Setting Regional hospital, Hong Kong.Participants One hundred women with postmenopausal bleeding scheduled for hysteroscopy from October 1998 to September 2001 were randomly assigned to receive either misoprostol or placebo vaginally before the operation. Main outcome measures The number of women requiring cervical dilatation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0
13

Year Published

2005
2005
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(29 citation statements)
references
References 11 publications
0
15
0
13
Order By: Relevance
“…In many studies which have evaluated the effect of misoprostol on cervical ripening, undissolved misoprostol tablets in vagina were reported and this may be a factor for ineffectiveness of vaginal misoprostol treatment. Fung et al (2002) did not show a significant difference in the incidence of undissolved medication when the drug was administered overnight, and about 5 hours are necessary for drug absorption with the assumption that the active ingredient drug was released while the tablet remained in vagina. In order to eliminate this possibility of inappropriate absorption, we have used enteral route for the administration of misoprostol.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In many studies which have evaluated the effect of misoprostol on cervical ripening, undissolved misoprostol tablets in vagina were reported and this may be a factor for ineffectiveness of vaginal misoprostol treatment. Fung et al (2002) did not show a significant difference in the incidence of undissolved medication when the drug was administered overnight, and about 5 hours are necessary for drug absorption with the assumption that the active ingredient drug was released while the tablet remained in vagina. In order to eliminate this possibility of inappropriate absorption, we have used enteral route for the administration of misoprostol.…”
Section: Discussionmentioning
confidence: 99%
“…However, only a few studies had been reported on postmenopausal misoprostol use for cervical ripening and these studies had shown no beneficial effect (Ngai et al 2001;Fung et al 2002). Presence of beneficial effect of misoprostol only during premenopausal women questioned the possible effect of reproductive hormones on ameliorating activity of misoprostol on cervical ripening.…”
Section: © 2005 Tohoku University Medical Pressmentioning
confidence: 99%
“…it amounts to 35% of gynae OPD visits and 25% of gynaecological surgeries and this incidence rises to 65% in peri and postmenopausal age (1) This condition has enormous consequences with regard to social life, morbidity and clinical workload (2)(3)(4) . Hysteroscopy as an outpatient procedure is an important method for diagnosis of AUB (5,6) . Although the major role of out-patient hysteroscopy in the management of AUB, is diagnostic, there is scope for simple operative procedures such as polypectomy, and targeted endometrial biopsy (6) .…”
Section: Discussionmentioning
confidence: 99%
“…The majority do not find a significant ripening effect of misoprostol compared with placebo. [2][3][4] A couple of studies have suggested that misoprostol is effective: Barcaite et al 5 and Thomas et al 6 have concluded in their studies that misoprostol is effective for cervical ripening in postmenopausal women. However, their studies have methodological flaws.…”
Section: Sirmentioning
confidence: 99%